Age-related vulnerability
Typical setting: Incidence rises substantially with age.
Declining mitochondrial, proteostatic and repair capacity reduces neuronal resilience, although Parkinson’s is not an inevitable part of ageing.
Parkinson’s module
Understand Parkinson’s disease as progressive nigrostriatal dopamine loss that alters basal ganglia circuit output, producing bradykinesia, rigidity, tremor and wide-ranging non-motor dysfunction.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Most disease is sporadic, with interacting age, genetic and environmental influences.
Typical setting: Incidence rises substantially with age.
Declining mitochondrial, proteostatic and repair capacity reduces neuronal resilience, although Parkinson’s is not an inevitable part of ageing.
Typical setting: Family history or younger-onset disease may suggest variants such as LRRK2, GBA, PRKN or PINK1.
Different genes affect lysosomes, mitochondria, kinase signalling or synaptic protein handling and produce heterogeneous risk and phenotypes.
Typical setting: Some pesticide or solvent exposures are associated epidemiologically.
Mitochondrial or oxidative injury may increase risk, but exposure history rarely proves the cause in one person.
Typical setting: Cumulative traumatic exposure.
Neuroinflammation and protein-handling disruption may increase later parkinsonism risk, while single minor injuries are not determinative.
Typical setting: Dopamine-blocking medicines, vascular disease or structural disorders.
Parkinsonian signs can result without idiopathic nigral Lewy disease, making medication review and pattern recognition essential.
Mechanism chain
Nigral neuron loss shifts basal ganglia output towards excessive movement suppression.
Alpha-synuclein misfolding, impaired lysosomal clearance, mitochondrial dysfunction and inflammation interact in vulnerable neurons.
Substantia nigra pars compacta cell loss progressively reduces dopamine delivery to the dorsal striatum.
Keep exploring